Stock Market News
Latest financial news · Updated May 23, 2026
Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play
The panel's discussion on ARCT highlights significant risks, including cash burn, dilution, and reliance on a single Phase 2 trial …
Bath & Body Works Jumps 11% Monday — Should You Make an Aggressive Buy to Bet on a BBWI Stock Rebound?
The panel consensus is bearish on BBWI, with concerns over fundamental deterioration, high capex, and unsustainable margins despite an Amazon …
Stocks Climb on Hopes for an End to Iran War
Despite market optimism driven by geopolitical de-escalation hopes, panelists agree that persistent supply disruptions, weak economic data, and potential stagflation …
After a Record Bull Run, Is the Cattle Market Headed for Collapse?
The panel generally agreed that while the cattle market faces risks like margin compression and potential demand shifts, a collapse …
Here’s Why You Don’t Bet Against This Dividend King
The panelists have a neutral to bearish sentiment on JNJ, with concerns about patent cliffs, stagnant growth, and high valuation, …
J.Jill Q4 Earnings Call Highlights
The panelists generally agree that J.Jill is facing severe challenges, including structural tariff headwinds, deteriorating margins, and weak sales. The …
FREYR Battery Q4 Earnings Call Highlights
The panel is largely bearish on T1 Energy, citing execution risks, funding gaps, and supply chain fragility. The company's pivot …
KOSPI Due For Another Jump On Thursday
The panel generally agrees that the KOSPI's 8.44% bounce is a relief rally rather than a trend reversal, driven by …
The Under-the-Radar Nuclear Energy Stock That Could Supercharge Your Passive Income
PNW is a stable utility income play with a 3.69% yield, but its high debt-to-equity ratio, 71% payout ratio, and …
Why Dave & Buster's Stock Surged Today
The panel is divided on PLAY's future prospects. While some see potential in menu upgrades and new attractions, others question …
Why Eli Lilly Stock Trounced the Market Today
The panel is divided on Eli Lilly's Foundayo approval, with concerns about real-world efficacy, payer adoption, and operational execution outweighing …
These 3 Energy Stocks May Outperform the S&P 500 in 2026
The panel's net takeaway is that the article's thesis of sustained high oil prices through 2026 due to Middle East …